Skip to main content
MainBoardListed
Kronox Lab Sciences Limited Logo

Kronox Lab Sciences Limited IPO

Kronox Lab Sciences Limited IPO

IPO Date :
Issue Price :
Allotment Date :
Listing Date :
List Price :
Lot Size:
Subscription:
Listed Price: ₹ 164.95 (+21.29%)

Kronox Lab Sciences Limited's has transitioned to a publicly listed entity following its IPO debut on 10-06-2024 at the NSE, BSE exchange. The public offering successfully raised 95,70,000 Shares, consisting of TBDin new capital and ₹130.15 Cr in existing shareholder sales.

The IPO featured a competitive price range of ₹129 to ₹136 and minimum application size of 110 shares. Market reception was evidenced through subscription activity between 03-06-2024 and 05-06-2024, reflecting investor appetite for the offering.

Allotment of shares was completed on 06-06-2024, distributing equity to successful applicants. The listing marked the beginning of the company's journey as a publicly traded corporation, subject to market dynamics and regulatory oversight.

Kronox Lab IPO Details
Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

IPO Reservation
Kronox Lab IPO Key Performance Indicator
Company Financials ( In Crores )

Kronox Lab IPO About Company

Kronox Lab Sciences Limited, founded in 2008, is a leading manufacturer of high-purity speciality chemicals used in various industries like pharmaceuticals, biotech, agrochemicals, personal care, and animal health. The company offers 185+ products such as phosphate, sulphate, chloride, and EDTA derivatives, serving customers in India and over 20 countries including the USA, Australia, UK, and China. Kronox operates three manufacturing units in Vadodara, Gujarat with a total capacity of 7,242 TPA. Their facilities follow strict quality standards with certifications like ISO, FSSC, Kosher, Halal, GMP, and GLP. The company focuses heavily on research and development, working on 122 new products and serving 592+ customers in the last three years, with many returning for repeat orders.


Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."


Kronox Lab IPO Strength Factors

  1. Wide Product Range and Versatile Uses: Kronox Lab Sciences Limited provides 185+ high-purity speciality fine chemicals used in pharmaceuticals, nutraceuticals, biotech, agrochemicals, personal care, metal refineries, and animal health industries.
  2. Strong Customer Bonds: The company serves 592+ customers, out of which 141 customers place repeat orders, showing customer trust and satisfaction.
  3. Tough Market Entry & Exit: Strict product quality standards and lengthy customer approval processes make it difficult for new competitors to enter or exit the market, helping Kronox maintain a strong market position.

Kronox Lab IPO Risk Factors

  1. Strict Industry Standards Compliance: If the company doesn't follow domestic and international industry standards, customers may reject the products, which could harm the company's reputation.
  2. Dependence on Third-Party Logistics: The company relies on outside logistics providers for transportation. This could lead to delays, higher costs, theft, accidents, or product loss during delivery, affecting business operations and profits.
  3. High P/E Ratio: The company’s stock is priced much higher than the industry average, which could be risky if the market shifts or if the company fails to meet its growth expectations.

Kronox Lab IPO Lead Manager(s)

  • Pantomath Capital Advisor Private Limited

Kronox Lab IPO Promoter(s)

  1. Jogindersingh Jaswal
  2. Ketan Ramani
  3. Pritesh Ramani

Kronox Lab IPO Company Details

Kronox Lab Sciences Limited
Phone:
address:

Kronox Lab IPO Registrar

Kfin Technologies Limited
Name:
Phone:

Kronox Lab IPO FAQs